<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35563179</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>26</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differences in Tau Seeding in Newborn and Adult Wild-Type Mice.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">4789</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23094789</ELocationID>
        <Abstract>
          <AbstractText>Alzheimer's disease (AD) and other tauopathies are common neurodegenerative diseases in older adults; in contrast, abnormal tau deposition in neurons and glial cells occurs only exceptionally in children. Sarkosyl-insoluble fractions from sporadic AD (sAD) containing paired helical filaments (PHFs) were inoculated unilaterally into the thalamus in newborn and three-month-old wild-type C57BL/6 mice, which were killed at different intervals from 24 h to six months after inoculation. Tau-positive cells were scanty and practically disappeared at three months in mice inoculated at the age of a newborn. In contrast, large numbers of tau-positive cells, including neurons and oligodendrocytes, were found in the thalamus of mice inoculated at three months and killed at the ages of six months and nine months. Mice inoculated at the age of newborn and re-inoculated at the age of three months showed similar numbers and distribution of positive cells in the thalamus at six months and nine months. This study shows that (a) differences in tau seeding between newborn and young adults may be related to the ratios between 3Rtau and 4Rtau, and the shift to 4Rtau predominance in adults, together with the immaturity of connections in newborn mice, and (b) intracerebral inoculation of sAD PHFs in newborn mice does not protect from tau seeding following intracerebral inoculation of sAD PHFs in young/adult mice.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ferrer</LastName>
            <ForeName>Isidro</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0001-9888-8754</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andrés-Benito</LastName>
            <ForeName>Pol</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3000-0338</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garcia-Esparcia</LastName>
            <ForeName>Paula</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>López-Gonzalez</LastName>
            <ForeName>Irene</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valiente</LastName>
            <ForeName>Diego</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0002-0924-8454</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jordán-Pirla</LastName>
            <ForeName>Mónica</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carmona</LastName>
            <ForeName>Margarita</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-9275-9000</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bellvitge Biomedical Research Centre-IDIBELL, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Network Centre of Biomedical Research of Neurodegenerative Diseases-CIBERNED, Institute of Health Carlos III, Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sala-Jarque</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Parc Científic de Barcelona, Baldiri Reixac sn, 08020 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Baldiri Reixac sn, 08020 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gil</LastName>
            <ForeName>Vanessa</ForeName>
            <Initials>V</Initials>
            <Identifier Source="ORCID">0000-0002-7782-5575</Identifier>
            <AffiliationInfo>
              <Affiliation>Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Parc Científic de Barcelona, Baldiri Reixac sn, 08020 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Baldiri Reixac sn, 08020 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Del Rio</LastName>
            <ForeName>José Antonio</ForeName>
            <Initials>JA</Initials>
            <Identifier Source="ORCID">0000-0002-5214-4909</Identifier>
            <AffiliationInfo>
              <Affiliation>Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia, Barcelona Institute for Science and Technology, Parc Científic de Barcelona, Baldiri Reixac sn, 08020 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Baldiri Reixac sn, 08020 Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024801" MajorTopicYN="Y">Tauopathies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="N">newborn</Keyword>
        <Keyword MajorTopicYN="N">tau seeding and spreading</Keyword>
        <Keyword MajorTopicYN="N">thalamus</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>1</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35563179</ArticleId>
        <ArticleId IdType="pmc">PMC9099670</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms23094789</ArticleId>
        <ArticleId IdType="pii">ijms23094789</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Duyckaerts C.  Alzheimer’s Disease. In: Kovacs G.G., editor. Neuropathology of Neurodegenerative Diseases: A Practical Guide. Cambridge University; Cambridge, UK: 2015. pp. 80–108.</Citation>
        </Reference>
        <Reference>
          <Citation>Kovacs G.G., editor. Neuropathology of Neurodegenerative Diseases: A Practical Guide. Cambridge University; Cambridge, UK: 2015. Tauopathies; pp. 109–148.</Citation>
        </Reference>
        <Reference>
          <Citation>Braak H., Braak E. Neuropathological Stageing of Alzheimer-Related Changes. Acta Neuropathol. 1991;82:239–259. doi: 10.1007/BF00308809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00308809</ArticleId>
            <ArticleId IdType="pubmed">1759558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer I. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia. Progr. Neurobiol. 2012;97:38–51. doi: 10.1016/j.pneurobio.2012.03.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pneurobio.2012.03.005</ArticleId>
            <ArticleId IdType="pubmed">22459297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braak H., Del Tredici K. The Preclinical Phase of the Pathological Process Underlying Sporadic Alzheimer’s Disease. Brain. 2015;138:2814–2833. doi: 10.1093/brain/awv236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awv236</ArticleId>
            <ArticleId IdType="pubmed">26283673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Šimić G., Leko M.B., Wray S., Harrington C., Delalle I., Milošević N.J., Bažadona D., Buee L., de Silva R., Di Giovanni G., et al.  Monoaminergic Neuropathology in Alzheimer’s Disease. Prog. Neurobiol. 2017;151:101–138. doi: 10.1016/j.pneurobio.2016.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pneurobio.2016.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC5061605</ArticleId>
            <ArticleId IdType="pubmed">27084356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masters C., Bateman R., Blennow K., Rowe C.C., Sperling R.A., Cummings J.L. Alzheimer’s Disease. Nat. Rev. Dis. Prim. 2015;1:15056. doi: 10.1038/nrdp.2015.56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrdp.2015.56</ArticleId>
            <ArticleId IdType="pubmed">27188934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeTure M.A., Dickson D.W. The Neuropathological Diagnosis of Alzheimer’s Disease. Mol. Neurodegener. 2019;14:32. doi: 10.1186/s13024-019-0333-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13024-019-0333-5</ArticleId>
            <ArticleId IdType="pmc">PMC6679484</ArticleId>
            <ArticleId IdType="pubmed">31375134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jellinger K.A. Neuropathology of the Alzheimer’s Continuum: An Update. Free Neuropathol. 2020;1:32.</Citation>
        </Reference>
        <Reference>
          <Citation>Avila J., Perry G. A Multilevel View of the Development of Alzheimer’s Disease. Neuroscience. 2021;457:283–293. doi: 10.1016/j.neuroscience.2020.11.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2020.11.015</ArticleId>
            <ArticleId IdType="pubmed">33246061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer I., Santpere G., Van Leeuwen F.W. Argyrophilic Grain Disease. Brain. 2008;131:1416–1432. doi: 10.1093/brain/awm305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awm305</ArticleId>
            <ArticleId IdType="pubmed">18234698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed Z., Bigio E.H., Budka H., Dickson D.W., Ferrer I., Ghetti B., Giaccone G., Hatanpaa K.J., Holton J.L., Josephs K.A., et al.  Globular Glial Tauopathies (GGT): Consensus Recommendations. Acta Neuropathol. 2013;126:537–544. doi: 10.1007/s00401-013-1171-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-013-1171-0</ArticleId>
            <ArticleId IdType="pmc">PMC3914659</ArticleId>
            <ArticleId IdType="pubmed">23995422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crary J.F., Trojanowski J.Q., Schneider J.A., Abisambra J.F., Abner E.L., Alafuzoff I., Arnold S.E., Attems J., Beach T.G., Bigio E.H., et al.  Primary Age-Related Tauopathy (PART): A Common Pathology Associated with Human Aging. Acta Neuropathol. 2014;128:755–766. doi: 10.1007/s00401-014-1349-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId>
            <ArticleId IdType="pmc">PMC4257842</ArticleId>
            <ArticleId IdType="pubmed">25348064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovacs G.G., Ferrer I., Grinberg L.T., Alafuzoff I., Attems J., Budka H., Cairns N.J., Crary J.F., Duyckaerts C., Ghetti B., et al.  Aging-Related Tau Astrogliopathy (ARTAG): Harmonized Evaluation Strategy. Acta Neuropathol. 2016;131:87–102. doi: 10.1007/s00401-015-1509-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-015-1509-x</ArticleId>
            <ArticleId IdType="pmc">PMC4879001</ArticleId>
            <ArticleId IdType="pubmed">26659578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armstrong M.J. Progressive Supranuclear Palsy: An Update. Curr. Neurol. Neurosci. Rep. 2018;18:12. doi: 10.1007/s11910-018-0819-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11910-018-0819-5</ArticleId>
            <ArticleId IdType="pubmed">29455271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saranza G.M., Whitwell J.L., Kovacs G.G., Lang A.E. Corticobasal Degeneration. Int. Rev. Neurobiol. 2019;149:87–136. doi: 10.1016/bs.irn.2019.10.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.irn.2019.10.014</ArticleId>
            <ArticleId IdType="pubmed">31779825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovacs G.G., Ghetti B., Goedert M. Classification of Diseases with Accumulation of Tau Protein. Neuropathol. Appl. Neurobiol. 2022;48:e12792. doi: 10.1111/nan.12792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nan.12792</ArticleId>
            <ArticleId IdType="pubmed">35064600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Spillantini M.G. Ordered Assembly of Tau Protein and Neurodegeneration. Adv. Exp. Med. Biol. 2019;184:3–21. doi: 10.1007/978-981-32-9358-8_1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-981-32-9358-8_1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnsten A.F.T., Datta D., Del Tredici K., Braak H. Hypothesis: Tau Pathology Is an Initiating Factor in Sporadic Alzheimer’s Disease. Alzheimer’s Dement. 2021;17:115–124. doi: 10.1002/alz.12192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/alz.12192</ArticleId>
            <ArticleId IdType="pmc">PMC7983919</ArticleId>
            <ArticleId IdType="pubmed">33075193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jucker M., Walker L.C. Pathogenic Protein Seeding in Alzheimer Disease and Other Neurodegenerative Disorders. Ann. Neurol. 2011;70:532–540. doi: 10.1002/ana.22615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.22615</ArticleId>
            <ArticleId IdType="pmc">PMC3203752</ArticleId>
            <ArticleId IdType="pubmed">22028219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis J., Dickson D.W. Propagation of Tau Pathology: Hypotheses, Discoveries, and Yet Unresolved Questions from Experimental and Human Brain Studies. Acta Neuropathol. 2016;131:27–48. doi: 10.1007/s00401-015-1507-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-015-1507-z</ArticleId>
            <ArticleId IdType="pubmed">26576562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arendt T., Stieler J., Holzer M. Tau and Tauopathies. Brain Res. Bull. 2016;126:238–292. doi: 10.1016/j.brainresbull.2016.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainresbull.2016.08.018</ArticleId>
            <ArticleId IdType="pubmed">27615390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Eisenberg D.S., Crowther R.A. Propagation of Tau Aggregates and Neurodegeneration. Annu. Rev. Neurosci. 2017;40:189–210. doi: 10.1146/annurev-neuro-072116-031153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-neuro-072116-031153</ArticleId>
            <ArticleId IdType="pubmed">28772101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Spillantini M.G. Propagation of Tau Aggregates. Mol. Brain. 2017;10:18. doi: 10.1186/s13041-017-0298-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13041-017-0298-7</ArticleId>
            <ArticleId IdType="pmc">PMC5450399</ArticleId>
            <ArticleId IdType="pubmed">28558799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibbons G.S., Lee V.M.Y., Trojanowski J.Q. Mechanisms of Cell-to-Cell Transmission of Pathological Tau. JAMA Neurol. 2019;76:101–108. doi: 10.1001/jamaneurol.2018.2505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2018.2505</ArticleId>
            <ArticleId IdType="pmc">PMC6382549</ArticleId>
            <ArticleId IdType="pubmed">30193298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrés-Benito P., Carmona M., Jordán M., Fernández-Irigoyen J., Santamaría E., del Rio J.A., Ferrer I. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum. Int. J. Mol. Sci. 2022;23:718.  doi: 10.3390/ijms23020718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms23020718</ArticleId>
            <ArticleId IdType="pmc">PMC8775896</ArticleId>
            <ArticleId IdType="pubmed">35054902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L., Drouet V., Wu J.W., Witter M.P., Small S.A., Clelland C., Duff K. Trans-Synaptic Spread of Tau Pathology In Vivo. PLoS ONE. 2012;7:e31302.  doi: 10.1371/journal.pone.0031302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0031302</ArticleId>
            <ArticleId IdType="pmc">PMC3270029</ArticleId>
            <ArticleId IdType="pubmed">22312444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Calignon A., Polydoro M., Suárez-Calvet M., William C., Adamowicz D.H., Kopeikina K.J., Pitstick R., Sahara N., Ashe K.H., Carlson G.A., et al.  Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease. Neuron. 2012;73:685–697. doi: 10.1016/j.neuron.2011.11.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2011.11.033</ArticleId>
            <ArticleId IdType="pmc">PMC3292759</ArticleId>
            <ArticleId IdType="pubmed">22365544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed Z., Cooper J., Murray T.K., Garn K., McNaughton E., Clarke H., Parhizkar S., Ward M.A., Cavallini A., Jackson S., et al.  A Novel in Vivo Model of Tau Propagation with Rapid and Progressive Neurofibrillary Tangle Pathology: The Pattern of Spread Is Determined by Connectivity, Not Proximity. Acta Neuropathol. 2014;127:667–683. doi: 10.1007/s00401-014-1254-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-014-1254-6</ArticleId>
            <ArticleId IdType="pmc">PMC4252866</ArticleId>
            <ArticleId IdType="pubmed">24531916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dujardin S., Lecolle K., Caillierez R., Bégard S., Zommer N., Lachaud C., Carrier S., Dufour N., Aurégan G., Winderickx J., et al.  Neuron-to-Neuron Wild-Type Tau Protein Transfer through a Trans-Synaptic Mechanism: Relevance to Sporadic Tauopathies. Acta Neuropathol. Commun. 2014;2:14. doi: 10.1186/2051-5960-2-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2051-5960-2-14</ArticleId>
            <ArticleId IdType="pmc">PMC3922636</ArticleId>
            <ArticleId IdType="pubmed">24479894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mudher A.A., Colin M., Dujardin S., Medina M., Dewachter I., Naini S.M.A.S., Mandelkow E.-M.E., Mandelkow E.E., Buee L., Goedert M.M., et al.  What Is the Evidence That Tau Pathology Spreads through Prion-Like Propagation? Acta Neuropathol. Commun. 2017;5:99. doi: 10.1186/s40478-017-0488-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40478-017-0488-7</ArticleId>
            <ArticleId IdType="pmc">PMC5735872</ArticleId>
            <ArticleId IdType="pubmed">29258615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dujardin S., Bégard S., Caillierez R., Lachaud C., Delattre L., Carrier S., Loyens A., Galas M.-C., Bousset L., Melki R., et al.  Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein. PLoS ONE. 2014;9:e100760.  doi: 10.1371/journal.pone.0100760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0100760</ArticleId>
            <ArticleId IdType="pmc">PMC4074092</ArticleId>
            <ArticleId IdType="pubmed">24971751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Balaji V., Kaniyappan S., Krüger L., Irsen S., Tepper K., Chandupatla R., Maetzler W., Schneider A., Mandelkow E., et al.  The Release and Trans-Synaptic Transmission of Tau via Exosomes. Mol. Neurodegener. 2017;12:5. doi: 10.1186/s13024-016-0143-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13024-016-0143-y</ArticleId>
            <ArticleId IdType="pmc">PMC5237256</ArticleId>
            <ArticleId IdType="pubmed">28086931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guix F.X., Corbett G.T., Cha D.J., Mustapic M., Liu W., Mengel D., Chen Z., Aikawa E., Young-Pearse T., Kapogiannis D., et al.  Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles. Int. J. Mol. Sci. 2018;19:663.  doi: 10.3390/ijms19030663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19030663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polanco J.C., Li C., Durisic N., Sullivan R., Götz J. Exosomes Taken up by Neurons Hijack the Endosomal Pathway to Spread to Interconnected Neurons. Acta Neuropathol. Commun. 2018;6:10. doi: 10.1186/s40478-018-0514-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40478-018-0514-4</ArticleId>
            <ArticleId IdType="pmc">PMC5815204</ArticleId>
            <ArticleId IdType="pubmed">29448966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng C., Trojanowski J.Q., Lee V.M. Protein transmission in neurodegenerative diseases. Nat. Rev. Neurol. 2020;16:199–212. doi: 10.1038/s41582-020-0333-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId>
            <ArticleId IdType="pubmed">32203399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tardivel M., Bégard S., Bousset L., Dujardin S., Coens A., Melki R., Buée L., Colin M. Tunneling Nanotube (TNT)-Mediated Neuron-to Neuron Transfer of Pathological Tau Protein Assemblies. Acta Neuropathol. Commun. 2016;4:117. doi: 10.1186/s40478-016-0386-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40478-016-0386-4</ArticleId>
            <ArticleId IdType="pmc">PMC5096005</ArticleId>
            <ArticleId IdType="pubmed">27809932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuerde D., Kimura T., Miyasaka T., Furusawa K., Shimozawa A., Hasegawa M., Ando K., Hisanaga S.-I. Isoform-Independent and -Dependent Phosphorylation of Microtubule-Associated Protein Tau in Mouse Brain During Postnatal Development. J. Biol. Chem. 2018;293:1781–1793. doi: 10.1074/jbc.M117.798918.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M117.798918</ArticleId>
            <ArticleId IdType="pmc">PMC5798307</ArticleId>
            <ArticleId IdType="pubmed">29196605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hefti M.M., Kim S., Bell A.J., Betters R.K., Fiock K., Iida M.A., Smalley M.E., Farrell K., Fowkes M.E., Crary J.F. Tau Phosphorylation and Aggregation in the Developing Human Brain. J. Neuropathol. Exp. Neurol. 2019;78:930–938. doi: 10.1093/jnen/nlz073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jnen/nlz073</ArticleId>
            <ArticleId IdType="pmc">PMC6751069</ArticleId>
            <ArticleId IdType="pubmed">31504677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>López-González I., Aso E., Carmona M., Armand-Ugon M., Blanco R., Naudí A., Cabré R., Portero-Otin M., Pamplona R., Ferrer I. Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications with Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau. J. Neuropathol. Exp. Neurol. 2015;74:975–999. doi: 10.1097/NEN.0000000000000241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/NEN.0000000000000241</ArticleId>
            <ArticleId IdType="pubmed">26360374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iba M., Guo J.L., McBride J.D., Zhang B., Trojanowski J.Q., Lee V.M.-Y. Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer’s-Like Tauopathy. J. Neurosci. 2013;33:1024–1037. doi: 10.1523/JNEUROSCI.2642-12.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2642-12.2013</ArticleId>
            <ArticleId IdType="pmc">PMC3575082</ArticleId>
            <ArticleId IdType="pubmed">23325240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iba M., McBride J.D., Guo J.L., Zhang B., Trojanowski J.Q., Lee V.M.-Y. Tau Pathology Spread in PS19 Tau Transgenic Mice Following Locus Coeruleus (LC) Injections of Synthetic Tau Fibrils Is Determined by the LC’S Afferent and Efferent Connections. Acta Neuropathol. 2015;130:349–362. doi: 10.1007/s00401-015-1458-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-015-1458-4</ArticleId>
            <ArticleId IdType="pmc">PMC4545685</ArticleId>
            <ArticleId IdType="pubmed">26150341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peeraer E., Bottelbergs A., Van Kolen K., Stancu I.-C., Vasconcelos B., Mahieu M., Duytschaever H., Donck L.V., Torremans A., Sluydts E., et al.  Intracerebral Injection of Preformed Synthetic Tau Fibrils Initiates Widespread Tauopathy and Neuronal Loss in the Brains of Tau Transgenic Mice. Neurobiol. Dis. 2015;73:83–95. doi: 10.1016/j.nbd.2014.08.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.032</ArticleId>
            <ArticleId IdType="pmc">PMC4303592</ArticleId>
            <ArticleId IdType="pubmed">25220759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stancu I.-C., Vasconcelos B., Ris L., Wang P., Villers A., Peeraer E., Buist A., Terwel D., Baatsen P., Oyelami T., et al.  Templated Misfolding of Tau by Prion-Like Seeding Along Neuronal Connections Impairs Neuronal Network Function and Associated Behavioral Outcomes in Tau Transgenic Mice. Acta Neuropathol. 2015;129:875–894. doi: 10.1007/s00401-015-1413-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-015-1413-4</ArticleId>
            <ArticleId IdType="pmc">PMC4436846</ArticleId>
            <ArticleId IdType="pubmed">25862635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clavaguera F., Bolmont T., Crowther R.A., Abramowski D., Frank S., Probst A., Fraser G., Stalder A.K., Beibel M., Staufenbiel M., et al.  Transmission and Spreading of Tauopathy in Transgenic Mouse Brain. Nat. Cell Biol. 2009;11:909–913. doi: 10.1038/ncb1901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1901</ArticleId>
            <ArticleId IdType="pmc">PMC2726961</ArticleId>
            <ArticleId IdType="pubmed">19503072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clavaguera F., Akatsu H., Fraser G., Crowther R.A., Frank S., Hench J., Probst A., Winkler D.T., Reichwald J., Staufenbiel M., et al.  Brain Homogenates from Human Tauopathies Induce Tau Inclusions in Mouse Brain. Proc. Natl. Acad. Sci. USA. 2013;110:9535–9540. doi: 10.1073/pnas.1301175110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1301175110</ArticleId>
            <ArticleId IdType="pmc">PMC3677441</ArticleId>
            <ArticleId IdType="pubmed">23690619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clavaguera F., Lavenir I., Falcon B., Frank S., Goedert M., Tolnay M. “Prion-Like” Templated Misfolding in Tauopathies. Brain Pathol. 2013;23:342–349. doi: 10.1111/bpa.12044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bpa.12044</ArticleId>
            <ArticleId IdType="pmc">PMC8028860</ArticleId>
            <ArticleId IdType="pubmed">23587140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boluda S., Iba M., Zhang B., Raible K.M., Lee V.M.-Y., Trojanowski J.Q. Differential Induction and Spread of Tau Pathology in Young PS19 Tau Transgenic Mice Following Intracerebral Injections of Pathological Tau from Alzheimer’s Disease or Corticobasal Degeneration Brains. Acta Neuropathol. 2015;129:221–237. doi: 10.1007/s00401-014-1373-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-014-1373-0</ArticleId>
            <ArticleId IdType="pmc">PMC4305460</ArticleId>
            <ArticleId IdType="pubmed">25534024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo J.L., Narasimhan S., Changolkar L., He Z., Stieber A., Zhang B., Gathagan R., Iba M., McBride J.D., Trojanowski J.Q., et al.  Unique Pathological Tau Conformers from Alzheimer’s Brains Transmit Tau Pathology in Nontransgenic Mice. J. Exp. Med. 2016;213:2635–2654. doi: 10.1084/jem.20160833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20160833</ArticleId>
            <ArticleId IdType="pmc">PMC5110027</ArticleId>
            <ArticleId IdType="pubmed">27810929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Audouard E., Houben S., Masaracchia C., Yilmaz Z., Suain V., Authelet M., De Decker R., Buée L., Boom A., Leroy K., et al.  High–Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo. Am. J. Pathol. 2016;186:2709–2722. doi: 10.1016/j.ajpath.2016.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2016.06.008</ArticleId>
            <ArticleId IdType="pubmed">27497324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narasimhan S., Guo J.L., Changolkar L., Stieber A., McBride J.D., Silva L.V., He Z., Zhang B., Gathagan R.J., Trojanowski J.Q., et al.  Pathological tau strains from human brains recapitulate the diversity of tauopathies in non-transgenic mouse brain. J. Neurosci. 2017;37:11406–11423. doi: 10.1523/JNEUROSCI.1230-17.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1230-17.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5700423</ArticleId>
            <ArticleId IdType="pubmed">29054878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer I., García M.A., González I.L., Lucena D.D., Villalonga A.R., Tech M.C., Llorens F., Garcia-Esparcia P., Martinez-Maldonado A., Mendez M.F., et al.  Aging-Related Tau Astrogliopathy (ARTAG): Not Only Tau Phosphorylation in Astrocytes. Brain Pathol. 2018;28:965–985. doi: 10.1111/bpa.12593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bpa.12593</ArticleId>
            <ArticleId IdType="pmc">PMC8028270</ArticleId>
            <ArticleId IdType="pubmed">29396893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer I., García M.A., Carmona M., Benito P.A., Torrejón-Escribano B., Garcia-Esparcia P., Del Rio J.A. Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies. Front. Aging Neurosci. 2019;11:112. doi: 10.3389/fnagi.2019.00112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnagi.2019.00112</ArticleId>
            <ArticleId IdType="pmc">PMC6546889</ArticleId>
            <ArticleId IdType="pubmed">31191295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer I., Benito P.A., Zelaya M.V., Aguirre M.E.E., Carmona M., Ausín K., Lachén-Montes M., Fernández-Irigoyen J., Santamaría E., Del Rio J.A. Familial Globular Glial Tauopathy Linked to MAPT Mutations: Molecular Neuropathology and Seeding Capacity of a Prototypical Mixed Neuronal and Glial Tauopathy. Acta Neuropathol. 2020;139:735–771. doi: 10.1007/s00401-019-02122-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-019-02122-9</ArticleId>
            <ArticleId IdType="pmc">PMC7096369</ArticleId>
            <ArticleId IdType="pubmed">31907603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer I., Zelaya M.V., García M.A., Carmona M., López-González I., Andrés-Benito P., Lidón L., Gavín R., Garcia-Esparcia P., Del Rio J.A. Relevance of Host Tau in Tau Seeding and Spreading in Tauopathies. Brain Pathol. 2020;30:298–318. doi: 10.1111/bpa.12778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bpa.12778</ArticleId>
            <ArticleId IdType="pmc">PMC8018022</ArticleId>
            <ArticleId IdType="pubmed">31397930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braak H., Del Tredici K. The Pathological Process Underlying Alzheimer’s Disease in Individuals under Thirty. Acta Neuropathol. 2010;121:171–181. doi: 10.1007/s00401-010-0789-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-010-0789-4</ArticleId>
            <ArticleId IdType="pubmed">21170538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braak H., Thal D.R., Ghebremedhin E., del Tredici K. Stages of the Pathologic Process in Alzheimer Disease: Age Categories from 1 to 100 Years. J. Neuropathol. Exp. Neurol. 2011;70:960–969. doi: 10.1097/NEN.0b013e318232a379.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/NEN.0b013e318232a379</ArticleId>
            <ArticleId IdType="pubmed">22002422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duyckaerts C. Tau Pathology in Children and Young Adults: Can You Still Be Unconditionally Baptist? Acta Neuropathol. 2011;121:145–147. doi: 10.1007/s00401-010-0794-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-010-0794-7</ArticleId>
            <ArticleId IdType="pubmed">21225273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elobeid A., Soininen H., Alafuzoff I. Hyperphosphorylated Tau in Young and Middle-Aged Subjects. Acta Neuropathol. 2011;123:97–104. doi: 10.1007/s00401-011-0906-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-011-0906-z</ArticleId>
            <ArticleId IdType="pmc">PMC3249177</ArticleId>
            <ArticleId IdType="pubmed">22160320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calderón-Garcidueñas L., Franco-Lira M., Mora-Tiscareño A., Medina-Cortina H., Torres-Jardón R., Kavanaugh M. Early Alzheimer’s and Parkinson’s Disease Pathology in Urban Children: Friend Versus Foe responses—It Is Time to Face the Evidence. BioMed Res. Int. 2013;2013:161687. doi: 10.1155/2013/161687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/161687</ArticleId>
            <ArticleId IdType="pmc">PMC3581281</ArticleId>
            <ArticleId IdType="pubmed">23509683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wegmann S., Bennett R.E., Delorme L., Robbins A.B., Hu M., MacKenzie D., Kirk M.J., Schiantarelli J., Tunio N., Amaral A.C., et al.  Experimental Evidence for the Age Dependence of Tau Protein Spread in the Brain. Sci. Adv. 2019;5:eaaw6404. doi: 10.1126/sciadv.aaw6404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/sciadv.aaw6404</ArticleId>
            <ArticleId IdType="pmc">PMC6594764</ArticleId>
            <ArticleId IdType="pubmed">31249873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and Sequencing of the CDNA Encoding a Core Protein of the Paired Helical Filament of Alzheimer Disease: Identification as the Microtubule-Associated Protein Tau. Proc. Natl. Acad. Sci. USA. 1988;85:4051–4055. doi: 10.1073/pnas.85.11.4051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.85.11.4051</ArticleId>
            <ArticleId IdType="pmc">PMC280359</ArticleId>
            <ArticleId IdType="pubmed">3131773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Spillantini M., Jakes R., Rutherford D., Crowther R. Multiple Isoforms of Human Microtubule-Associated Protein Tau: Sequences and Localization in Neurofibrillary Tangles of Alzheimer’s Disease. Neuron. 1989;3:519–526. doi: 10.1016/0896-6273(89)90210-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0896-6273(89)90210-9</ArticleId>
            <ArticleId IdType="pubmed">2484340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosik K.S., Orecchio L.D., Bakalis S., Neve R.L. Developmentally Regulated Expression of Specific Tau Sequences. Neuron. 1989;2:1389–1397. doi: 10.1016/0896-6273(89)90077-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0896-6273(89)90077-9</ArticleId>
            <ArticleId IdType="pubmed">2560640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brion J.-P., Smith C., Couck A.-M., Gallo J.-M., Anderton B.H. Developmental Changes in τ Phosphorylation: Fetal τ Is Transiently Phosphorylated in a Manner Similar to Paired Helical Filament-τ Characteristic of Alzheimer’s Disease. J. Neurochem. 1993;61:2071–2080. doi: 10.1111/j.1471-4159.1993.tb07444.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb07444.x</ArticleId>
            <ArticleId IdType="pubmed">8245963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janke C., Beck M., Stahl T., Holzer M., Brauer K., Bigl V., Arendt T. Phylogenetic Diversity of the Expression of the Microtubule-Associated Protein Tau: Implications for Neurodegenerative Disorders. Mol. Brain Res. 1999;68:119–128. doi: 10.1016/S0169-328X(99)00079-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0169-328X(99)00079-0</ArticleId>
            <ArticleId IdType="pubmed">10320789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takuma H., Arawaka S., Mori H. Isoforms Changes of Tau Protein During Development in Various Species. Dev. Brain Res. 2003;142:121–127. doi: 10.1016/S0165-3806(03)00056-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-3806(03)00056-7</ArticleId>
            <ArticleId IdType="pubmed">12711363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee G., Cowan N., Kirschner M. The Primary Structure and Heterogeneity of Tau Protein from Mouse Brain. Science. 1988;239:285–288. doi: 10.1126/science.3122323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.3122323</ArticleId>
            <ArticleId IdType="pubmed">3122323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M., Spillantini M., Cairns N., Crowther R. Tau Proteins of Alzheimer Paired Helical Filaments: Abnormal Phosphorylation of All Six Brain Isoforms. Neuron. 1992;8:159–168. doi: 10.1016/0896-6273(92)90117-V.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0896-6273(92)90117-V</ArticleId>
            <ArticleId IdType="pubmed">1530909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goode B.L., Feinstein S.C. Identification of a Novel Microtubule Binding and Assembly Domain in the Developmentally Regulated Inter-Repeat Region of Tau. J. Cell Biol. 1994;124:769–782. doi: 10.1083/jcb.124.5.769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.124.5.769</ArticleId>
            <ArticleId IdType="pmc">PMC2119949</ArticleId>
            <ArticleId IdType="pubmed">8120098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gustke N., Trinczek B., Biernat J., Mandelkow E.-M. Domains of Tau Protein and Interactions with Microtubules. Biochemistry. 1994;33:9511–9522. doi: 10.1021/bi00198a017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi00198a017</ArticleId>
            <ArticleId IdType="pubmed">8068626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brion J.-P., Tremp G., Octave J.-N. Transgenic Expression of the Shortest Human Tau Affects Its Compartmentalization and Its Phosphorylation as in the Pretangle Stage of Alzheimer’s Disease. Am. J. Pathol. 1999;154:255–270. doi: 10.1016/S0002-9440(10)65272-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)65272-8</ArticleId>
            <ArticleId IdType="pmc">PMC1853433</ArticleId>
            <ArticleId IdType="pubmed">9916940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández F., Pérez M., De Barreda E.G., Goñi-Oliver P., Avila J. Tau as a Molecular Marker of Development, Aging and Neurodegenerative Disorders. Curr. Aging Sci. 2008;1:56–61. doi: 10.2174/1874609810801010056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1874609810801010056</ArticleId>
            <ArticleId IdType="pubmed">20021373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spillantini M.G., Goedert M. Tau Pathology and Neurodegeneration. Lancet Neurol. 2013;12:609–622. doi: 10.1016/S1474-4422(13)70090-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(13)70090-5</ArticleId>
            <ArticleId IdType="pubmed">23684085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Götz J., Probst A., Spillantini M., Schäfer T., Jakes R., Bürki K., Goedert M. Somatodendritic Localization and Hyperphosphorylation of Tau Protein in Transgenic Mice Expressing the Longest Human Brain Tau Isoform. EMBO J. 1995;14:1304–1313. doi: 10.1002/j.1460-2075.1995.tb07116.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/j.1460-2075.1995.tb07116.x</ArticleId>
            <ArticleId IdType="pmc">PMC398215</ArticleId>
            <ArticleId IdType="pubmed">7729409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattsson N., Sävman K., Österlundh G., Blennow K., Zetterberg H. Converging Molecular Pathways in Human Neural Development and Degeneration. Neurosci. Res. 2010;66:330–332. doi: 10.1016/j.neures.2009.11.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neures.2009.11.012</ArticleId>
            <ArticleId IdType="pubmed">19961883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hefti M.M., Farrell K., Kim S., Bowles K.R., Fowkes M.E., Raj T., Crary J.F. High-Resolution Temporal and Regional Mapping of MAPT Expression and Splicing in Human Brain Development. PLoS ONE. 2018;13:e0195771.  doi: 10.1371/journal.pone.0195771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0195771</ArticleId>
            <ArticleId IdType="pmc">PMC5892924</ArticleId>
            <ArticleId IdType="pubmed">29634760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bullmann T., de Silva R., Holzer M., Mori H., Arendt T. Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus. 2007;17:98–102. doi: 10.1002/hipo.20255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hipo.20255</ArticleId>
            <ArticleId IdType="pubmed">17183532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McMillan P., Korvatska E., Poorkaj P., Evstafjeva Z., Robinson L., Greenup L., Leverenz J., Schellenberg G.D., D’Souza I. Tau Isoform Regulation Is Region- and Cell-Specific in Mouse Brain. J. Comp. Neurol. 2008;511:788–803. doi: 10.1002/cne.21867.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.21867</ArticleId>
            <ArticleId IdType="pmc">PMC2845852</ArticleId>
            <ArticleId IdType="pubmed">18925637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu C., Götz J. Profiling Murine Tau With 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, With the 1N Isoform Being Enriched in the Nucleus. PLoS ONE. 2013;8:e84849.  doi: 10.1371/journal.pone.0084849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0084849</ArticleId>
            <ArticleId IdType="pmc">PMC3875548</ArticleId>
            <ArticleId IdType="pubmed">24386422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panda D., Samuel J.C., Massie M., Feinstein S.C., Wilson L. Differential Regulation of Microtubule Dynamics by Three- and Four-Repeat Tau: Implications for the Onset of Neurodegenerative Disease. Proc. Natl. Acad. Sci. USA. 2003;100:9548–9553. doi: 10.1073/pnas.1633508100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1633508100</ArticleId>
            <ArticleId IdType="pmc">PMC170955</ArticleId>
            <ArticleId IdType="pubmed">12886013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan W.X., Mao T., Dudman J.T. Inputs to the Dorsal Striatum of the Mouse Reflect the Parallel Circuit Architecture of the Forebrain. Front. Neuroanat. 2010;4:147. doi: 10.3389/fnana.2010.00147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnana.2010.00147</ArticleId>
            <ArticleId IdType="pmc">PMC3014656</ArticleId>
            <ArticleId IdType="pubmed">21212837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jesuthasan S. The Thalamo-Habenula Projection Revisited. Semin. Cell Dev. Biol. 2018;78:116–119. doi: 10.1016/j.semcdb.2017.08.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2017.08.023</ArticleId>
            <ArticleId IdType="pubmed">28803896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donovan S.L., McCasland J.S. GAP-43 Is Critical for Normal Targeting of Thalamocortical and Corticothalamic, But Not Trigeminothalamic Axons in the Whisker Barrel System. Somatosens. Mot. Res. 2008;25:33–47. doi: 10.1080/08990220701830696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08990220701830696</ArticleId>
            <ArticleId IdType="pubmed">18344146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graziano A., Liu X.-B., Murray K.D., Jones E.G. Vesicular Glutamate Transporters Define Two Sets of Glutamatergic Afferents to the Somatosensory Thalamus and Two Thalamocortical Projections in the Mouse. J. Comp. Neurol. 2008;507:1258–1276. doi: 10.1002/cne.21592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.21592</ArticleId>
            <ArticleId IdType="pubmed">18181146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bezdudnaya T., Keller A. Laterodorsal Nucleus of the Thalamus: A Processor of Somatosensory Inputs. J. Comp. Neurol. 2008;507:1979–1989. doi: 10.1002/cne.21664.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.21664</ArticleId>
            <ArticleId IdType="pmc">PMC2800129</ArticleId>
            <ArticleId IdType="pubmed">18273888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tlamsa A.P., Brumberg J.C. Organization and Morphology of Thalamocortical Neurons of Mouse Ventral Lateral Thalamus. Somatosens. Mot. Res. 2010;27:34–43. doi: 10.3109/08990221003646736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08990221003646736</ArticleId>
            <ArticleId IdType="pmc">PMC2839898</ArticleId>
            <ArticleId IdType="pubmed">20141408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooks B.M., Mao T., Gutnisky D.A., Yamawaki N., Svoboda K., Shepherd G.M.G. Organization of Cortical and Thalamic Input to Pyramidal Neurons in Mouse Motor Cortex. J. Neurosci. 2013;33:748–760. doi: 10.1523/JNEUROSCI.4338-12.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4338-12.2013</ArticleId>
            <ArticleId IdType="pmc">PMC3710148</ArticleId>
            <ArticleId IdType="pubmed">23303952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins D., Anastasiades P.G., Marlin J.J., Carter A.G. Reciprocal Circuits Linking the Prefrontal Cortex with Dorsal and Ventral Thalamic Nuclei. Neuron. 2018;98:366–379.e4. doi: 10.1016/j.neuron.2018.03.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2018.03.024</ArticleId>
            <ArticleId IdType="pmc">PMC6422177</ArticleId>
            <ArticleId IdType="pubmed">29628187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schroeder S.K., Joly-Amado A., Gordon M.N., Morgan D. Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies. J. Neuroimmune Pharmacol. 2015;11:9–25. doi: 10.1007/s11481-015-9637-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11481-015-9637-6</ArticleId>
            <ArticleId IdType="pmc">PMC4746105</ArticleId>
            <ArticleId IdType="pubmed">26538351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crandall J.E., Caviness V.S., Jr. Thalamocortical Connections in Newborn Mice. J. Comp. Neurol. 1984;228:542–556. doi: 10.1002/cne.902280407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.902280407</ArticleId>
            <ArticleId IdType="pubmed">6490968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evrard A., Ropert N. Early Development of the Thalamic Inhibitory Feedback Loop in the Primary Somatosensory System of the Newborn Mice. J. Neurosci. 2009;29:9930–9940. doi: 10.1523/JNEUROSCI.1671-09.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1671-09.2009</ArticleId>
            <ArticleId IdType="pmc">PMC6666591</ArticleId>
            <ArticleId IdType="pubmed">19657043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drummond E., Pires G., MacMurray C., Askenazi M., Nayak S., Bourdon M., Safar J., Ueberheide B., Wisniewski T. Phosphorylated Tau Interactome in the Human Alzheimer’s Disease Brain. Brain. 2020;143:2803–2817. doi: 10.1093/brain/awaa223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awaa223</ArticleId>
            <ArticleId IdType="pmc">PMC7526722</ArticleId>
            <ArticleId IdType="pubmed">32812023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kampers T., Pangalos M., Geerts H., Wiech H., Mandelkow E. Assembly of Paired Helical Filaments from Mouse Tau: Implications for the Neurofibrillary Pathology in Transgenic Mouse Models for Alzheimer’s Disease. FEBS Lett. 1999;451:39–44. doi: 10.1016/S0014-5793(99)00522-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-5793(99)00522-0</ArticleId>
            <ArticleId IdType="pubmed">10356980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sayas C.L., Medina M., Cuadros R., Ollá I., García E., Pérez M., Ferrer I., Hernández F., Avila J. Role of Tau N-Terminal Motif in the Secretion of Human Tau by End Binding Proteins. PLoS ONE. 2019;14:e0210864.  doi: 10.1371/journal.pone.0210864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0210864</ArticleId>
            <ArticleId IdType="pmc">PMC6342323</ArticleId>
            <ArticleId IdType="pubmed">30668577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paxinos G., Franklin K.B.J.  The Mouse Brain in Stereotaxic Coordinates. 5th ed. Elsevier; Amsterdam, The Netherlands: 2019. </Citation>
        </Reference>
        <Reference>
          <Citation>Schröder H., Moser N., Huggenberger S.  Neuroanatomy of the Mouse. Springer International Publishing; Berlin, Germany: 2020. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-030-19898-5</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
